(Q32068631)

6 July 2017

Safety of 2 recombinant human immunodeficiency virus type 1 (HIV-1) envelope vaccines in neonates born to HIV-1-infected women (English)

1 reference

6 July 2017

0 references

L Mofenson

7

0 references

Coleen K. Cunningham

1

object named as

C K Cunningham

1 reference

6 July 2017

Elizabeth J. McFarland

10

object named as

E J McFarland

1 reference

6 July 2017

D W Wara

2

1 reference

6 July 2017

M Kang

3

1 reference

6 July 2017

T Fenton

4

1 reference

6 July 2017

E Hawkins

5

1 reference

6 July 2017

J McNamara

6

1 reference

6 July 2017

A M Duliege

8

1 reference

6 July 2017

D Francis

9

1 reference

6 July 2017

W Borkowsky

11

1 reference

6 July 2017

Pediatric AIDS Clinical Trials Group 230 Collaborators

12

1 reference

6 July 2017

language of work or name

English

0 references

publication date

28 February 2001

1 reference

Clinical Infectious Diseases

6 July 2017

1 reference

6 July 2017

32

1 reference

6 July 2017

801-807

1 reference

6 July 2017

5

1 reference

Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus

6 July 2017

1 reference

Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial

21 January 2018

1 reference

Antiretroviral drugs as a public health intervention for pregnant HIV-infected women in rural South Africa: an issue of cost-effectiveness and capacity.

21 January 2018

1 reference

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

21 January 2018

1 reference

Lymphoproliferative Responses to Recombinant HIV‐1 Envelope Antigens in Neonates and Infants Receiving gp120 Vaccines

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/319215

1 reference

6 July 2017

1 reference